ORIC Pharmaceuticals Inc. (ORIC)
NASDAQ: ORIC
· Real-Time Price · USD
11.17
0.40 (3.71%)
At close: Sep 05, 2025, 12:00 PM
3.71% (1D)
| Bid | 11.16 |
| Market Cap | 1.08B |
| Revenue (ttm) | 1.07M |
| Net Income (ttm) | -137.25M |
| EPS (ttm) | -1.92 |
| PE Ratio (ttm) | -5.82 |
| Forward PE | -6.46 |
| Analyst | Buy |
| Ask | 11.18 |
| Volume | 238,545 |
| Avg. Volume (20D) | 1,011,609 |
| Open | 10.91 |
| Previous Close | 10.77 |
| Day's Range | 10.86 - 11.27 |
| 52-Week Range | 3.90 - 14.67 |
| Beta | 1.69 |
About ORIC
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ORIC
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for ORIC stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts3 months ago
+33.5%
Oric Pharmaceuticals shares are trading higher aft...
Unlock content with
Pro Subscription
3 months ago
+3.29%
ORIC Pharmaceuticals shares are trading higher after the company announced preliminary efficacy and safety data from its ongoing Phase 1b trial of ORIC-944. Additionally, the company announced a $125 million private placement, which was priced at an 18% premium to its 10-day trailing volume-weighted average price.
